GSK Plc

NYSE: GSK
$39.30
+$0.46 (+1.2%)
Closing Price on July 24, 2024

GSK Chart and Intraday Price

GSK Company Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GB
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 85,517.17M USD
Shares Outstanding 2,029,100,000
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, arexvy, influenza, and pandemic vaccines. It also provides medicine products for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. The company sells its products under the Anoro Ellipta, Nucala, Trelegy Ellipta, Ventolin, Xevudy, Keppra, Augmentin, Zejula, Blenrep, Jemperli, Ojjaara/Omjjara, Benlysta, Benlysta, Jesduvroq, Duvroq, Apretude, Cabenuva/Vocabria + Rekambys, Rukobia, Dovato, Juluca, Triumeq, Tivicay, Arexvy, Bexsero, Menveo, Synflorix, and Shingrix brand names. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

GSK Articles

Private healthcare sure does seem to be working well in America, doesn’t it? With skyrocketing healthcare costs with diminishing returns, a lower life expectancy, unofficial waitlists, and absurdly...
Analysts have been cutting ratings and price targets recently, but here are four stocks that defying the downward pressure.
Wednesday's top analyst upgrades and downgrades included Amazon, AMC Entertainment, Apollo Global Management, Apple, Block, Capital One Financial, Carlyle, CVS Health, Etsy, Fox, Gilead Sciences,...
Friday’s additional top analyst upgrades and downgrades were on Freeport-McMoRan, GSK, Intel, L3Harris Technologies, Occidental Petroleum, Roku, Six Flags Entertainment, Spirit AeroSystems, Sprouts...
Friday's top analyst upgrades and downgrades included Chipotle Mexican Grill, CrowdStrike, First Solar, Fortinet, Franklin Resources, GSK, Intel, Nvidia, Shoals Technologies, Spirit AeroSystems,...
Friday's top analyst upgrades and downgrades included Alcoa, Blue Apron, Brixmor Property, Enterprise Products Partners, FIGS, GSK, Healthcare Realty Trust, Nordstrom, Range Resources, Southwestern...
Monday's top analyst upgrades and downgrades included Chewy, Cloudflare, Coca-Cola, Doximity, Ideanomics, GlaxoSmithKline, Micron Technology, SoFi Technologies, Teladoc Health, Twitter and Walmart.
Friday afternoon's analyst upgrades and downgrades included BigCommerce, Citrix, GlaxoSmithKline, Nikola, Regeneron, Shake Shack and more.
Thursday’s top analyst upgrades and downgrades included Analog Devices, Activision Blizzard, BP, Clorox, EA, MGM PayPal, Square and more.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Alexion, DraftKings, Inovio, Netflix, Snowflake and more.
Thursday's top analyst upgrades and downgrades included Apple, Best Buy, Electronic Arts, FireEye, Match, PayPal, Qualcomm and ViacomCBS.
Wednesday's top analyst upgrades and downgrades included Altria, Boeing, Coca-Cola, GlaxoSmithKline, Halliburton, Kroger, Netflix and Pioneer Natural Resources.
Vir Biotechnology shares jumped on Tuesday after the firm announced that it would be expanding its late-stage COVID-19 study in conjunction with GlaxoSmithKline.
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United...
Nvidia has announced it will partner with GlaxoSmithKline to apply its artificial intelligence and supercomputers for the drug and vaccine discovery process.